|
2024
|
Invention
|
Monoclonal antibody and a method thereof.
The present invention relates to a humanized IgG1 isot... |
|
|
P/S
|
Pharmaceutical compositions and preparations, namely, pharmaceutical compositions and preparation... |
|
|
Invention
|
A process for the preparation of glucagon. The present invention relates to a process for prepara... |
|
2023
|
P/S
|
Biological preparations for use in industry and science; Chemicals for use in industry and science |
|
|
Invention
|
Use of itolizumab to reduce phosphorylation of cd6.
The present invention discloses a key mechan... |
|
|
Invention
|
Formulations of antibody.
A stable pharmaceutically formulation containing antibody, a buffer, a... |
|
|
P/S
|
Medical fluid injectors |
|
2022
|
P/S
|
Chemicals for use in industry, science and photography, as
well as in agriculture, horticulture ... |
|
|
P/S
|
Pharmaceutical preparations, namely, safety pre-filled injections in the nature of Insulin inject... |
|
|
Invention
|
Preparation method of echinocandin nucleus. The present invention relates to an immobilized deacy... |
|
|
Invention
|
Purification of liraglutide.
The present invention provides for novel and improved liraglutide p... |
|
|
Invention
|
Purification of liraglutide. The present invention provides for novel and improved liraglutide pr... |
|
|
Invention
|
Process for preparation of cabozantinib.
The present invention provides for novel amorphous soli... |
|
|
Invention
|
Process for preparation of cabozantinib. The present invention provides for novel amorphous solid... |
|
|
Invention
|
Synthesis of teduglutide.
The present invention provides for novel synthetic approach of solid p... |
|
|
Invention
|
Synthesis of teduglutide. The present invention provides for novel synthetic approach of solid ph... |
|
2021
|
Invention
|
Monoclonal antibody and a method of use for the treatment of lupus.
The present invention relate... |
|
|
Invention
|
Anti-egfr1-pd1 targeted/immunomodulatory fusion protein. The present invention relates generally ... |
|
|
Invention
|
Use of a cd6 binding partner and method based thereon.
The present disclosure relates to methods... |
|
|
Invention
|
Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a corona... |
|
|
Invention
|
Crystalline forms of lenalidomide. The present invention provides for novel co-crystals of lenali... |
|
2020
|
Invention
|
Forms of binimetinib and process for preparation thereof. Amorphous forms of Binimetinib and proc... |
|
|
Invention
|
Trisodium sacubitril valsartan and process for its preparation. The present invention provides fo... |
|
|
Invention
|
Fusion immunomodulatory proteins and methods for making same.
The present invention relates gene... |
|
|
Invention
|
Crystalline forms of 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol. The present invention ... |
|
|
Invention
|
Monoclonal antibody and a method thereof. The present invention relates to a humanized IgG1 isoty... |
|
|
Invention
|
Crystalline linagliptin intermediate and process for preparation of linagliptin. The present inve... |
|
|
P/S
|
Pharmaceutical preparations for treating autoimmune diseases.
Medical apparatus, instruments and ... |
|
|
P/S
|
Pharmaceuticals and medical preparations. Medical devices, apparatus and instruments. |
|
|
Invention
|
Purification of glp-1 analogues.
The present invention provides for purification of liraglutide ... |
|
|
Invention
|
Purification of glp-1 analogues. The present invention provides for purification of liraglutide u... |
|
|
Invention
|
Preparative crystallization of recombinant human insulin.
The present invention discloses a meth... |
|
|
Invention
|
Preparative crystallization of recombinant human insulin. The present invention discloses a metho... |
|
2019
|
Invention
|
Crystalline forms of posaconazole intermediate and process for the preparation of amorphous posac... |
|
|
Invention
|
Ctla4/pd1 targeted/immunomodulatory fusion proteins. The present invention relates generally to t... |
|
|
Invention
|
Method and use of controlling postprandial glucose levels in a subject. Disclosed is a method of ... |
|
|
Invention
|
Immunotherapy methods using anti-pd-l1 antibodies in combination with egfr1 targeted-tgf-beta imm... |
|
2018
|
Invention
|
Use of a cd6 binding partner and method based thereon. The present disclosure relates to methods ... |
|
|
Invention
|
Synthesis of icatibant.
The present invention relates to the efficient solid-phase synthesis of ... |
|
|
Invention
|
Peptide mapping method for sequence identification of insulin and insulin analogues. The inventio... |
|
|
Invention
|
Polymorphic forms of dasatinib. The present invention provides for the dasatinib-thymine co-cryst... |
|
|
P/S
|
Pharmaceutical compositions and preparations for treatment of cancer or tumours |
|
2017
|
Invention
|
Synthesis of liraglutide. The present invention relates to the efficient solid-phase synthesis of... |
|
|
Invention
|
Rapid and efficient de-glycosylation of glycoproteins. The present invention discloses rapid and ... |
|
|
Invention
|
Amorphous trisodium sacubitril valsartan and process for its preparation. The present invention p... |
|
|
Invention
|
Monoclonal antibody and a method of use for the treatment of lupus. The present invention relates... |
|
|
Invention
|
Bio-analytical method for insulin analogues.
The present invention provides for a specific and s... |
|
2014
|
P/S
|
[ CHEMICAL PRODUCTS USED IN INDUSTRY, SCIENCE, PHOTOGRAPHY, AGRICULTURE, HORTICULTURE AND FORESTR... |
|
|
P/S
|
Chemical products used in industry, science, photography,
agriculture, horticulture, forestry; m... |
|
|
P/S
|
Pharmaceutical, veterinary preparations used in treatment of diabetes, renal disorder, cancer, he... |
|
2010
|
P/S
|
Pharmaceutical preparation of chemically modified oral calcitonin for the treatment of osteoporos... |
